Wells Fargo helped pull the market lower after falling 4.6 per cent. The San Francisco-based bank reported weaker profit and revenue for the latest quarter than expected, with analysts citing lower trading fees and other miscellaneous items. Bank of America fell 3.8 per cent despite reporting a stronger profit than analysts expected, with some consternation about the size of its upcoming expenses. Citigroup, which is in the midst of a turnaround under Chair and CEO Jane Fraser, fell 3.3 per cent following i ...

Vancouver, British Columbia--(Newsfile Corp. - January 14, 2026) - Pioneer AI Foundry Inc. (Cboe CA: JPEG) (FSE: 6NU0) ("Pioneer" or the "Company") announces that it has filed its interim financial statements for the quarter ended November 30, 2025 and its related management's discussion and analysis.During the second quarter, Pioneer recorded its first revenue, totaling $46,480, derived from a Kora AI services contract. While the Company reported a net loss of $2,292,591 for the quarter, this was primaril ...

Group 1 - Boeing has reached tentative settlements with a Canadian man regarding the 2019 Ethiopian Air 737 MAX crash [1]

Core Viewpoint - Vital Farms (VITL) is experiencing a decline in stock price and is under scrutiny for its upcoming earnings report, which is expected to show significant growth in earnings per share (EPS) and revenue compared to the previous year [1][2]. Financial Performance - The company is forecasted to report an EPS of $0.38, reflecting a 65.22% increase from the same quarter last year [2]. - Revenue is anticipated to reach $213.26 million, indicating a 28.48% growth compared to the corresponding quarter of the prior year [2]. - For the full year, analysts expect earnings of $1.44 per share and revenue of $759.16 million, representing a 22.03% increase in earnings but no change in revenue from last year [3]. Analyst Estimates - Recent modifications to analyst estimates for Vital Farms suggest a favorable outlook on the company's business health and profitability [4]. - The Zacks Consensus EPS estimate has decreased by 0.95% over the past month, and the company currently holds a Zacks Rank of 3 (Hold) [6]. Valuation Metrics - Vital Farms is trading at a Forward P/E ratio of 18.36, which is a premium compared to its industry's Forward P/E of 12.9 [7]. - The Food - Miscellaneous industry, part of the Consumer Staples sector, has a Zacks Industry Rank of 178, placing it in the bottom 28% of over 250 industries [7][8].

Core Viewpoint - Delta Air Lines is experiencing a stock price decline, but analysts see this as a buying opportunity due to expectations of sustained growth and robust capital returns [2][3][5] Group 1: Stock Performance - Delta's stock was trading at $67.89 when Seaport Global set a price target of $88, indicating a potential increase of about 29.62% [2][5] - The current stock price is $68.11, reflecting a decrease of 1.76% or $1.22 [3] - During the trading day, Delta's stock reached a low of $67.55 and a high of $70.72, with a yearly high of $73.16 and a low of $34.74 [4] Group 2: Market Capitalization and Trading Volume - Delta's market capitalization stands at approximately $44.47 billion [4][5] - The trading volume for Delta's shares is 5,394,401 [4][5] Group 3: Analyst Expectations - Analysts expect sustained growth, acceleration, and margin strength to support a robust capital return [3][5]

Core Viewpoint - Leidos Holdings, Inc. is a significant entity in the technology and defense sectors, with upcoming financial results expected to provide insights into its performance and market position [1] Group 1: Analyst Ratings and Price Targets - Citigroup maintains a "Buy" rating for Leidos, raising its price target from $218 to $232, reflecting confidence in the company's future performance [2][6] - Stifel Nicolaus analyst Jonathan Siegmann sets a price target of $220 for Leidos but downgrades the stock from "Buy" to "Hold," indicating a more cautious outlook [3][6] Group 2: Financial Metrics - Leidos has a price-to-earnings (P/E) ratio of approximately 17.21, suggesting a moderate valuation of its earnings [4][6] - The price-to-sales ratio is about 1.39, indicating investor willingness to pay per dollar of sales [4] - The enterprise value to sales ratio stands at around 1.64, reflecting the company's total valuation relative to its sales [4] Group 3: Financial Health Indicators - Leidos has a debt-to-equity ratio of approximately 1.07, indicating a balanced approach to financing through debt and equity [5][6] - The current ratio of around 1.62 suggests that Leidos is well-positioned to cover its short-term liabilities with its short-term assets [5] - An earnings yield of about 5.81% provides a comprehensive view of Leidos' financial health and investment potential [5]

Core Viewpoint - Varonis Systems, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its ability to convert its customer base to a SaaS model, resulting in a significant decline in stock price following disappointing financial results [3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Varonis provided overly positive statements while concealing material adverse facts about its customer conversion capabilities, leading to reduced annual recurring revenue (ARR) growth potential [3]. - On October 28, 2025, Varonis reported a significant miss in ARR and lowered its full-year guidance, attributing this to weaker-than-expected renewals and conversions in its subscription business [3]. - Following the announcement, Varonis' stock price plummeted from $63.00 per share to $32.34 per share, marking a decline of approximately 48.67% in just one day [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as February 4, 2025, to October 28, 2025, and shareholders are encouraged to register for potential lead plaintiff appointment [3][4]. - The deadline for shareholders to register for the class action is March 9, 2026, and there is no cost or obligation to participate [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [4]. Group 3: Law Firm Background - The Gross Law Firm, which is handling the case, is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Fermi Inc. (NASDAQ: FRMI). Shareholders who purchased shares of FRMI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fermi-inc-loss-submission-form/?id=183094&from=3 CLASS PERIOD: This lawsuit is on behal ...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of StubHub Holdings, Inc. (NYSE: STUB). Shareholders who purchased shares of STUB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/stubhub-holdings-inc-loss-submission-form/?id=183088&from=3 CLASS PERIOD: Thi ...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/skye-bioscience-inc-loss-submission-form/?id=183083&from=3 CLASS PERIOD: Nov ...